Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin Added to CSII in Uncontrolled Type 2 Diabetes
NCT03563794Phase 4Unknown
- Sponsor
- First Affiliated Hospital of Xiamen University
- Start
- Jun 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by First Affiliated Hospital of Xiamen University. Status: unknown.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03563794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03563794.